Being
a high-tech
enterprise which principally engages in R&D of
drugs , Tianjin TaiPu
Pharmaceutical Science & Technology Development
Co., Ltd. (abbreviated as TP) was established
by Tianjin Institute of Pharmaceutical
Research(abbreviated as TIPR), natural person of
Synthesis Pharmaceutical Research Section and
Hangzhou Shengyou Pharmaceutical Technology
Development Co., Ltd in the end of 2002. Its
predecessor is Synthesis Pharmaceutical Research
Section of TIPR under the control of the State
Drug Administration.
Located at No.308 An shan Xi Dao at Nankai
district, Tianjin, TP’s labs cover around 1000
square meters. Equipped with precise apparatus
like HPLC、GC、UV-vis,
Dissolution Tester, Particle Size Analyzer and
general oral dosage form, freeze drier powder
injection and liquid injection etc., TP has an
excellent hardware environment and has
successfully installed and configured the
computer-controlled automatic mock poilt scale
production lab. Integrated the academic strength
of TIPR, TP can independently complete the
preclinical study of new drugs and chemical’s
poilt scale production research.
With strong capability and excellent technique,
TP is dedicated its energy and talent to the
development of the new chemistry drug in the
fields of cardio-cerebral vascular disease,
nervous system, respiratory system,
anti-infection, anti-virus. With efforts by our
researchers and administrative staff, we have
successfully completed these subjects including
9 subjects of Nation Key Technology R&D
Programme from the 7th Five-Year period to the
9th Five-Year period, 1 subject of The National
High Technology Research and Development
Programme of China (863 Program) and many
subjects of Key Technology R&D Programme of
Tianjin Municipal Science and Technology
Commission. TP has already succeeded in
developing many new drugs with mass-market、high-tech
and remarkable curative effect. TP has made
great contribution to adjusting drug structure
and promoting the people’s health.